The pathological CCM phenotypes in zebrafish embryos, CCM2-deficient human umbilical vein endothelial cells (HUVECs), and in a pre-clinical CCM3 mouse disease model, were suppressed by genetic or pharmacological CBX7 inhibition. Here, CCM2 is linked to cerebral cavernous malformation.